Main aim of the COMBAT-CAD-Study is to clarify, if the combination of stress testing with biomarkers improves the diagnostic accuracy. Hypothesis of our study is that diagnosis of CAD can be improved by adding biomarkers to solely stress testing for the workup of patients with suspected CAD or progress of already known CAD.
The COMBAT-CAD Study is an observational study with the aim to improve the diagnostic accuracy by a combination of stress testing with sensitive and specific biomarkers in detecting coronary artery disease or its progress. The main subjects are all patients with CAD or suspicion of CAD sent to the University Heart Center Hamburg. In these patients, ECG, laboratory examination, symptoms or transthoracic echocardiography in rest could not rule out CAD or progress of known CAD. The hypothesis of the study is that detection of CAD can be improved by adding biomarkers to stress testing for the diagnostic workup of patients with suspected CAD or progress of already known CAD.
Study Type
OBSERVATIONAL
Enrollment
850
Department of General and Interventional Cardiology, University Heart Center Hamburg
Hamburg, Germany
Diagnosis of coronary artery disease
The diagnosis of coronary artery disease through stress testing alone and combined with cardiac biomarkers.
Time frame: Within the initial diagnostic evaluation process (maximum within 30 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.